Tony Goodman

CIK: 0001717971

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADIL

ADIAL PHARMACEUTICALS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ADIL
ADIAL PHARMACEUTICALS, INC.
Apr 7, 2026
Award(A)
Direct
26.5K shares-
ADIL
ADIAL PHARMACEUTICALS, INC.
May 29, 2025
Award(A)
Stock Option (Right to Buy)
Direct
94K shares-

		Type	Shares	Price		Ownership
Apr 7, 2026	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A)	26,510	-	$0	Direct
May 29, 2025	ADIL ADIAL PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	94,000	-	-	Direct

1-2 of 2 transactions

About Goodman Tony

Goodman Tony (SEC CIK 0001717971) files insider reports with the SEC as Chief Operating Officer of ADIAL PHARMACEUTICALS, INC. (ADIL).

Signal8 holds 2 ownership filings by Goodman Tony, all Form 4s, filed between Jun 2, 2025 and Apr 9, 2026. Those filings report 2 transactions, from May 29, 2025 to Apr 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Goodman Tony's filings is in GLEN ALLEN, VA.

Recent filings by Goodman Tony

Apr 7, 2026: Grant or award of ADIL shares (Form 4, code A).
May 29, 2025: Grant or award of ADIL derivative securities (Form 4, code A).

Other insiders filing for ADIAL PHARMACEUTICALS, INC. (ADIL)

Davidson Matt, President and CEO
Saiki Julie, Chief Strategy Officer
Economides Vassiliki, Chief Financial Officer
Young Wendy B., Director
Coastlands Capital LP, 10% Owner
Anderson J. Kermit, Director

How to read Form 4 transaction codes